Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Biochim Biophys Acta. 2011 Dec 19;1822(5):815–821. doi: 10.1016/j.bbadis.2011.12.008

Fig. 2. Therapeutic strategies targeting peroxynitrite.

Fig. 2

Targeting peroxynitrite (PN) with superoxide dismutase mimetics (SODm), peroxynitrite decomposition catalysts (PNDCs) which also have SODm activity, or with SO-sparing PNDCs (e.g. SRI6, SRI110) may provide a promising novel therapy for pain management.